Healthcare - Biotechnology - NASDAQ - NL
$ 24.9
-0.28 %
$ 2.3 B
Market Cap
-11.27
P/E
INCOME STATEMENT
12.8 M
REVENUE
-166 M
OPERATING INCOME
-160 M
NET INCOME
EFFICIENCY
Earnings Waterfall
NewAmsterdam Pharma Company N.V.
| Revenue | 12.8 M |
| Cost Of Revenue | 0 |
| Gross Profit | 12.8 M |
| Operating Expenses | 183 M |
| Operating Income | -166 M |
| Other Expenses | -5.46 M |
| Net Income | -160 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 12.8 | 95.9 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 12.8 | 95.9 | 0 | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 183.2 | 116.8 | 36.4 | 5.4 |
| Selling, General and Administrative Expenses | 29.8 | 18.2 | 5.3 | 1.4 |
| Research and Development Expenses | 159.4 | 81.0 | 25.5 | 4.0 |
| Operating Income | (165.7) | (3.3) | (30.7) | (5.4) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 6.8 | 0 | 0 | 0 |
| Total Other Income | 5.5 | (17.6) | (6.0) | (0.3) |
| Pre-Tax Income | (160.2) | (21.1) | (36.7) | (5.7) |
| NET INCOME | ||||
| Tax Provision | 27 K | 0 | 0 | 0 |
| Net Income | (176.9) | (21.1) | (36.7) | (5.7) |
| EPS | 2.15 | 1.11 | 3.34 | 1.15 |